My thoughts on this, is that it comes down to whether the FDA gives the EUA and we do the CD16 trial or we do the trial and then get the EUA.
I have always held out hope that it was the first and not the second, 25-75. Now after this PR I think we are are 50-50 maybe 60-40 EUA and then CD16 trial.